| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
| mRNA | ETP-46464 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
| mRNA | BMS-345541 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
| mRNA | selumetinib:MK-2206 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
| mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | -0.012 | 0.7 |
| mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.7 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | -0.013 | 0.7 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |